Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Line Treatment of Gastric Cancer”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)Looking for participantsNCT04592211
What this trial is testing

Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Who this might be right for
Gastric Cancer Stage IV
Yonsei University 71
Testing effectiveness (Phase 2)Ended earlyNCT03061708
What this trial is testing

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Who this might be right for
Stomach Neoplasms
Samsung Medical Center 1
Early research (Phase 1)Looking for participantsNCT06675136
What this trial is testing

Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

Who this might be right for
Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
City of Hope Medical Center 30
Early research (Phase 1)UnknownNCT03286244
What this trial is testing

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
AnewPharma 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186
What this trial is testing

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited 400
Testing effectiveness (Phase 2)Looking for participantsNCT07309185
What this trial is testing

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Who this might be right for
Stomach Neoplasms
Shandong Tumor Hospital 66
Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Testing effectiveness (Phase 2)Study completedNCT04770623
What this trial is testing

Docetaxel and Irinotecan in Gastric Cancer

Who this might be right for
Stomach CancerGastric CancerChemotherapy Effect
Menoufia University 32
Early research (Phase 1)Not Yet RecruitingNCT07031011
What this trial is testing

PD-1-M1-NK Cells in the Treatment of Advanced Gastric or Colorectal Cancer

Who this might be right for
Advanced Gastric or Colorectal Cancer
jiuwei cui 22
Post-approval studies (Phase 4)UnknownNCT05029453
What this trial is testing

Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy

Who this might be right for
Gastric CancerRandomized Controlled Study
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Ended earlyNCT02241720
What this trial is testing

Regorafenib Second Line Treatment of Metastatic or Advanced Upper GI Cancers

Who this might be right for
Upper GI Cancer
University of Utah 5
Testing effectiveness (Phase 2)Looking for participantsNCT05640830
What this trial is testing

Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy

Who this might be right for
HER2-positive Advanced Gastric Cancer
Kangbuk Samsung Hospital 47
Testing effectiveness (Phase 2)UnknownNCT04286711
What this trial is testing

Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
China Medical University, China 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT06992024
What this trial is testing

Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer

Who this might be right for
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT06499610
What this trial is testing

Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 44
Testing effectiveness (Phase 2)UnknownNCT03400592
What this trial is testing

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Peking University 55
Testing effectiveness (Phase 2)Study completedNCT01482299
What this trial is testing

RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression

Who this might be right for
Stomach Neoplasm
Asan Medical Center 45
Not applicableStudy completedNCT06666582
What this trial is testing

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer Stage IVSecond-line TreatmentRamucirumab Paclitaxel
Hellenic Cooperative Oncology Group 185
Large-scale testing (Phase 3)Study completedNCT00821990
What this trial is testing

Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Samsung Medical Center 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337447
What this trial is testing

Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Who this might be right for
Carcinoma, Neuroendocrine
Hospices Civils de Lyon 122
Load More Results